Shuwei Li

2.7k total citations
56 papers, 1.6k citations indexed

About

Shuwei Li is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Shuwei Li has authored 56 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Genetics and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Shuwei Li's work include Genetic factors in colorectal cancer (12 papers), Cancer Genomics and Diagnostics (10 papers) and Genomics and Rare Diseases (9 papers). Shuwei Li is often cited by papers focused on Genetic factors in colorectal cancer (12 papers), Cancer Genomics and Diagnostics (10 papers) and Genomics and Rare Diseases (9 papers). Shuwei Li collaborates with scholars based in United States, China and France. Shuwei Li's co-authors include Richard W. Roberts, Holly LaDuca, Hsiao‐Mei Lu, Rachel McFarland, Jefferey Chen, Aaron Elliott, Mary Helen Black, Wenbo Mu, Sha Tang and Zöe Powis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Shuwei Li

53 papers receiving 1.6k citations

Peers

Shuwei Li
Kenta Masuda Japan
Zhenbo Zhang China
Marie‐Claude Gingras United States
Jaran Apold Norway
Neng‐Yao Shih Taiwan
Gabrielle S. Le Provost United States
Christopher L. Reading United States
G. Skliris Canada
Suresh Mohla United States
Balraj Singh United States
Kenta Masuda Japan
Shuwei Li
Citations per year, relative to Shuwei Li Shuwei Li (= 1×) peers Kenta Masuda

Countries citing papers authored by Shuwei Li

Since Specialization
Citations

This map shows the geographic impact of Shuwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuwei Li more than expected).

Fields of papers citing papers by Shuwei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuwei Li. The network helps show where Shuwei Li may publish in the future.

Co-authorship network of co-authors of Shuwei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shuwei Li. A scholar is included among the top collaborators of Shuwei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuwei Li. Shuwei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torshizi, Abolfazl Doostparast, Dongnhu T. Truong, Liping Hou, et al.. (2024). Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson’s disease. Nature Communications. 15(1). 6430–6430. 5 indexed citations
2.
Guo, Jiao, Xiang Ren, Shuwei Li, et al.. (2024). Microbial synthesis of gallic acid and its glucoside β‐glucogallin. Biotechnology and Bioengineering. 121(11). 3527–3536. 8 indexed citations
3.
Tang, Wenjie, Jun Zhao, Xiangang Sun, et al.. (2022). The Genetic Characterization of a Novel Natural Recombinant Pseudorabies Virus in China. Viruses. 14(5). 978–978. 3 indexed citations
4.
Yu, Ting, Shuai Ben, Ling Ma, et al.. (2022). Genetic variants in autophagy-related gene ATG2B predict the prognosis of colorectal cancer patients receiving chemotherapy. Frontiers in Oncology. 12. 876424–876424. 2 indexed citations
5.
Li, Yan, et al.. (2021). Impaired bone healing by enoxaparin via inhibiting the differentiation of bone marrow mesenchymal stem cells towards osteoblasts. Journal of Bone and Mineral Metabolism. 40(1). 9–19. 6 indexed citations
6.
Wu, Yishuo, Hongjie Yu, Shuwei Li, et al.. (2020). Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer. European Urology Oncology. 3(2). 224–230. 38 indexed citations
7.
Black, Mary Helen, Shuwei Li, Holly LaDuca, et al.. (2020). Validation of a prostate cancer polygenic risk score. The Prostate. 80(15). 1314–1321. 19 indexed citations
8.
Guo, Wei, et al.. (2020). Hypoglycemia and Dandy-Walker variant in a Kabuki syndrome patient: a case report. BMC Medical Genetics. 21(1). 193–193. 2 indexed citations
9.
Xicola, Rosa M., Shuwei Li, Rachid Karam, et al.. (2019). Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria. Journal of Medical Genetics. 56(12). 838–843. 75 indexed citations
10.
Rana, Huma Q., Lily Hoang, Holly LaDuca, et al.. (2019). Genotype–phenotype associations among panel-based TP53+ subjects. Genetics in Medicine. 21(11). 2478–2484. 18 indexed citations
11.
Milam, Michael R., Shuwei Li, Amal Yussuf, et al.. (2019). Women with breast and uterine cancer are more likely to harbor germline mutations than women with breast or uterine cancer alone: A case for expanded gene testing. Gynecologic Oncology. 152(3). 612–617. 11 indexed citations
12.
Tian, Yuan, Tina Pesaran, Adam Chamberlin, et al.. (2019). REVEL and BayesDel outperform other in silico meta-predictors for clinical variant classification. Scientific Reports. 9(1). 12752–12752. 58 indexed citations
13.
Powis, Zöe, Carin R. Espenschied, Holly LaDuca, et al.. (2018). Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent. Cancer Genetics. 224-225. 12–20. 3 indexed citations
14.
Qian, Dajun, Shuwei Li, Yuan Tian, et al.. (2018). A Bayesian framework for efficient and accurate variant prediction. PLoS ONE. 13(9). e0203553–e0203553. 10 indexed citations
15.
Helbig, Katherine L., Kelly D. Farwell Hagman, Deepali N. Shinde, et al.. (2016). Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy. Genetics in Medicine. 18(9). 898–905. 217 indexed citations
16.
Hagman, Kelly D. Farwell, Deepali N. Shinde, Cameron Mroske, et al.. (2016). Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases. Genetics in Medicine. 19(2). 224–235. 34 indexed citations
17.
Leedom, Tracey P., Holly LaDuca, Rachel McFarland, et al.. (2016). Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers. Cancer Genetics. 209(9). 403–407. 36 indexed citations
18.
Yang, Shuang, Meiyao Wang, Lijun Chen, et al.. (2015). QUANTITY: An Isobaric Tag for Quantitative Glycomics. Scientific Reports. 5(1). 17585–17585. 56 indexed citations
19.
Pan, Miao, Gary G. Giulian, Yuan Wei, et al.. (2012). Formation of dAMP-glycerol and dAMP-Tris Derivatives by Thermococcus kodakaraensis DNA Primase. Journal of Biological Chemistry. 287(20). 16220–16229. 6 indexed citations
20.
Niu, Deng‐Ke, Wenru Hou, & Shuwei Li. (2005). mRNA-Mediated Intron Losses: Evidence from Extraordinarily Large Exons. Molecular Biology and Evolution. 22(6). 1475–1481. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenta Masuda Breakdown of academic impact, for papers by Zhenbo Zhang Breakdown of academic impact, for papers by Marie‐Claude Gingras Breakdown of academic impact, for papers by Jaran Apold Breakdown of academic impact, for papers by Neng‐Yao Shih Breakdown of academic impact, for papers by Gabrielle S. Le Provost Breakdown of academic impact, for papers by Christopher L. Reading Breakdown of academic impact, for papers by G. Skliris Breakdown of academic impact, for papers by Suresh Mohla Breakdown of academic impact, for papers by Balraj Singh
Rankless by CCL
2026